Laura M Dember,
Laura M Dember
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Renal-Electrolyte and Hypertension Division
Perelman School of Medicine, University of Pennsylvania
Founders 1
3400 Spruce Street
Philadelphia, PA 19104
Perelman School of Medicine, University of Pennsylvania
Founders 1
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-662-2488
Fax: 215-615-0349
Fax: 215-615-0349
Email:
laura.dember@uphs.upenn.edu
laura.dember@uphs.upenn.edu
Education:
B.A.
Yale College, New Haven, CT, 1984.
M.D.
Yale University School of Medicine, New Haven, CT, 1988.
Permanent linkB.A.
Yale College, New Haven, CT, 1984.
M.D.
Yale University School of Medicine, New Haven, CT, 1988.
Description of Clinical Expertise
Systemic amyloidosis, nephrotic syndrome, chronic kidney disease, endstage renal diseaseDescription of Research Expertise
Patient-oriented research (translational investigation, observational studies, and clinical trials) in chronic kidney disease, endstage renal disease, and systemic amyloidosisSelected Publications
Girnius S, Seldin DC, Quillen K, Dember LM, Segal A, Sanchorawala V: Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation. Bone Marrow Transplantation 46: 161-2, 2011.Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea NT, Sloan JM, Finn KT, Doros G, Blade J, Skinner M : Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood Page: {Epub ahead of print] 2011.
Girnius S, Dember L, Doros G, Skinner M : The changing face of AA amyloidosis: a single center experience Amyloid 18(S1): S221-3, 2011.
Dixon BS, Beck GJ, Dember LM, Vazquez MA, Greeberg A, Delmez JA, Allon M, Himmelfarb J, Hu B, Greene T, Radeva MK, Ikizler TA, Braden GL, Lawson JH, Cotton JR Jr, Kusek JW, Feldman HI Dialysis Access Consortium (DAC) Study Group : Effect of non-study aspirin on hemodialysis graft patency: A secondary cohort analysis of a clinical trial of extended release dipyridamole plus low dose aspirin. J Am Soc Nephrol 22(4): 773-81, 2011.
Specter R, Sanchorawa V, Seldin DS, Skinner M, Fennessey S, Finn K, Zeldis J, Dember LM: Kidney dysfunction during lenalidomide treatment for AL amyloidosis. Nephrology, Dialysis and Transplantation 26: 881-6, 2011.
Dember LM: Modern Treatment of Amyloidosis - Unresolved Questions. J Am Soc Nephrol 20(3): 469-72, Mar 2009.
Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR, Martin KJ, McNei JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI, Dialysis Access Consortium (DAC) Study Group: Effect of dipyridamole plus aspirin on hemodialysis graft patency NEJM 360: 2191-2201, 2009.
Dember LM, Beck GJ, Allon M, Delmez J, Dixon BS, Greenberg A, Himmelfarb J, Vazquez VA, Gassman JJ, Greene T, Radeva MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI. Dialysis Access Consortium (DAC) Study Group: Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized, controlled trial. JAMA 299: 2164-71, 2008.
Dember LM, Hawkins PN, Hazenberg BPC, Gorevic PD, Merlini G, Butriemene I, Livneh A, Lesnyak O, puechal X, Lachmann H, Obici L, Balshaw R, Garceau D, Hauck W. Skinner M: Eprodisate for the treatment of renal disease in AA amyloidosis. NEJM 356: 2349-60, 2007.
Dember LM: Fistulas first - But can they last? Clin J Am Soc Nephrol 6(13): 463-4, Mar 2011.